e-learning
resources
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary–Hepatic vascular Disorders (PHD)
R. Rodríguez-Roisin, M.J. Krowka , Ph. Hervé, et al.
Source:
Guideline 2004
Number:
2004
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Rodríguez-Roisin, M.J. Krowka , Ph. Hervé, et al.. Pulmonary–Hepatic vascular Disorders (PHD). Guideline 2004
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Pulmonary-Hepatic vascular Disorders (PHD)
Source: Eur Respir J 2004; 24 : 861-880
Year: 2004
Clinical phenotypes in pulmonary emboli identified by cluster analysis
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
Serum apelin 13 levels in patients with pulmonary embolism
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
Population pharmacokinetics (PK) of riociguat in patients (pts) with renal and hepatic impairment
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014
Vascular endothelial growth factor (VEGF) as marker of pulmonary hypertension in children with asthma
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
Characterization of circulating CD133+ progenitor cells in pulmonary arterial hypertension
Source: International Congress 2014 – Pathobiology of pulmonary hypertension
Year: 2014
Immune signatures in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014
Role of NMDA receptors in vascular remodelling associated to pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014
Female pulmonary arterial hypertension is associated with decreased microRNA96 expression
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014
Endothelial microparticles and progenitor cells in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014
ASK1 promotes maladaptive remodeling in a rodent model of pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014
Skeletal muscle impairment and proteomic profil in human pulmonary arterial hypertension
Source: International Congress 2014 – Pathobiology of pulmonary hypertension
Year: 2014
Muscle function and physical activity in patients with idiopathic pulmonary arterial hypertension (IPAH)
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
Outcomes in embolisations of pulmonary arterio-venous malformations
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014
Alteration of factors associated with coagulation in provoked pulmonary embolism
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
Association between antiphospholipid antibody type and level and pulmonary manifestations in APS
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
Smad1 deficiency and female gender contribute to the development of pulmonary hypertension
Source: International Congress 2014 – Pathobiology of pulmonary hypertension
Year: 2014
Detection of hepatopulmonary syndrome in patients with liver cirrhosis using 3D contrast echocardiography
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
Endothelial-to-mesenchymal transition in pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014
Isolated hypocapnia: A sign not to be neglected
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept